Search Results - "Goksin, Sule"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1
  2. 2

    The early and late efficacy of single‐pass fractional carbondioxide laser, fractional radiofrequency, and their combination in acne scars: A prospective, split‐face, single‐blinded, controlled clinical study by Kaçar, Nida, Dursun, Recep, Akbay, Merve, Gökşin, Şule

    Published in Dermatologic therapy (01-11-2020)
    “…We investigated the effectiveness of fractional carbon dioxide laser (FCO2) vs fractional radiofrequency (FRF) and FCO2 vs FRF plus FCO2 combination in the…”
    Get full text
    Journal Article
  3. 3

    Familial Actinic Lichen Planus: Three Cases from the Same Family by Gökşin, Şule, Aksoy, Sadrettin, Duygulu, Şeniz, Demirkan, Neşe Çallı

    Published in Annals of dermatology (01-10-2022)
    “…Actinic lichen planus (ALP) that affects sun-exposed areas of the skin is an uncommon variant of lichen planus. While ALP is commonly triggered by ultraviolet…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Dermoscopic Features of Cutaneous Vasculitis by Bakay, Ozge Sevil Karstarli, Kacar, Nida, Gonulal, Melis, Demirkan, Nese Calli, Cenk, Hülya, Goksin, Sule, Gural, Yunus

    Published in Dermatology practical & conceptual (01-01-2024)
    “…Dermoscopy has become widespread in the diagnosis of inflammatory skin diseases. Cutaneous vasculitis (CV) is characterized by inflammation of vessels, and a…”
    Get full text
    Journal Article
  7. 7

    Retrospective Evaluation of Clinical Profile and Comorbidities in Patients with Alopecia Areata by Goksin, Sule

    Published in Northern Clinics of Istanbul (01-01-2022)
    “…OBJECTIVE: The aim of the study was to determine the clinical profile of the patients with alopecia areata (AA) and whether or not any differences between the…”
    Get full text
    Journal Article
  8. 8

    Vitiligo in a patient with metastatic melanoma receiving human immunoglobulin G4 monoclonal antibody-nivolumab treatment/ Insan immunoglobulin G4 monoklonal antikor-nivolumab tedavisi alan metastatik melanomlu hastada vitiligo by Goksin, Sule, Degirmencioglu, Serkan

    Published in Türkderm (01-09-2022)
    “…Nivolumab is an immunotherapy drug developed to increase the ability of the immune system to target and kill cancer cells and is a human immunoglobulin G4…”
    Get full text
    Journal Article
  9. 9

    What can be learned from real-world data about chronic spontaneous urticaria? by Bakay, Ozge Sevil Karstarli, Kacar, Nida, Gul, Burak, Goksin, Sule, Gural, Yunus

    Published in Allergy and asthma proceedings (01-07-2024)
    “…Chronic spontaneous urticaria (CSU) is a common disease with complex pathogenesis. Patients' clinical characteristics and responses to treatment vary. We aimed…”
    Get more information
    Journal Article
  10. 10

    Vitiligo in a patient with metastatic melanoma receiving human immunoglobulin G4 monoclonal antibody-nivolumab treatment/ Insan immunoglobulin G4 monoklonal antikor-nivolumab tedavisi alan metastatik melanomlu hastada vitiligo by Goksin, Sule, Degirmencioglu, Serkan

    Published in Türkderm (01-09-2022)
    “…Nivolumab is an immunotherapy drug developed to increase the ability of the immune system to target and kill cancer cells and is a human immunoglobulin G4…”
    Get full text
    Journal Article
  11. 11

    Vitiligo in a patient with metastatic melanoma receiving human immunoglobulin G4 monoclonal antibodynivolumab treatment by Gökşin, Şule, Değirmencioğlu, Serkan

    Published in Türkderm (30-09-2022)
    “…Nivolumab is an immunotherapy drug developed to increase the ability of the immune system to target and kill cancer cells and is a human immunoglobulin G4…”
    Get full text
    Journal Article
  12. 12

    Efficacy of Topical Dapsone 5% Gel for the Treatment of Erythematotelangiectatic Rosacea: New Treatment Option With Old Drug by Gökşin, Şule, İmren, Işıl Göğem, Kaçar, Nida

    Published in Dermatology practical & conceptual (01-01-2024)
    “…Many topical drugs are used in the treatment of erythematotelangiectatic rosacea (ETR). However, dapsone 5% gel has never been used in ETR to date. To evaluate…”
    Get full text
    Journal Article
  13. 13

    Comparison of serum and lesional miRNA-1291 expressions in patients with bullous pemphigoid by Subaşı Gökşin,Şule, Urgancı,Buket Er, Göğem İmren,Işıl, Açıkbaş,İbrahim

    Published in Pamukkale Medical Journal (01-10-2022)
    “…Purpose: Bullous pemphigoid (BP) is an autoimmune disease increasing by age. miRNA-1291 is a microRNA that plays major role in many immune-mediated cutaneous…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Eroziv plantar liken planus: olağan bir hastalığın nadir klinik varyantı by GÖKŞİN, Şule SUBAŞI, DUYGULU, Şeniz, KAÇAR, Nida, DEMİRKAN, Neşe

    Published in Pamukkale Medical Journal (04-01-2021)
    “…Liken planus sık görülen mukoza ve deriyi tutan inflamatuar bir hastalıktır. Liken planus insidansı %0,1-4’tür. Palmoplantar liken planus ise hastalığın nadir…”
    Get full text
    Journal Article
  16. 16

    Deri döküntüsü ile başvuran iki olgu: COVID-19 olabilir mi? by Suna Seçil ÖZTÜRK DENİZ, ÖZAN, Sevgi, SOYAK, Firuze, GÖKŞİN, Şule SUBAŞI, KUTLU, Murat

    Published in Pamukkale Medical Journal (2022)
    “…Coronavirus hastalığı-19’un (COVID-19) en yaygın klinik bulguları ateş, öksürük ve solunum güçlüğü olmakla birlikte diğer sistem ve organ tutulumlarına ait…”
    Get full text
    Journal Article
  17. 17

    The use of interferon‐α2a as monotherapy in stage IB patients with mycosis fungoides: A retrospective chart review of patient outcomes by Gökşin, Şule, İmren, Işıl Göğem, Cenk, Hülya, Kaçar, Nida, Duygulu, Şeniz

    Published in Dermatologic therapy (01-04-2022)
    “…The aim of this study was to evaluate the response to IFN‐α2a treatment as monotherapy in stage IB patients with mycosis fungoides (MF) in second‐line therapy…”
    Get full text
    Journal Article
  18. 18